Frontlight ResearchEarly access
Fabry disease trials in United Kingdom
4 of 7 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleMaternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
- Where
- London
- People
- 10 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT06941025 - No phaseTaking peopleFabry Disease Registry & Pregnancy Sub-registry
- Where
- Belfast, Birmingham, Cambridge, London, Manchester, Salford
- People
- 9,000 worldwide
- Run by
- Genzyme, a Sanofi Company
See details and how to joinNCT00196742 - No phaseTaking peopleA Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
- Where
- Edgbaston, London, Salford
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT06663358 - No phaseTaking peopleNational Registry of Rare Kidney Diseases
- Where
- Bristol
- People
- 35,000
- Run by
- UK Kidney Association
See details and how to joinNCT06065852